Intratumoral microbiota might modulate anti-tumor immunity in many ways, including activating the STING and PERK pathways, promoting lymph node maturation, and enhancing cellular immunity mediated by bacterial peptides (References and citations are displayed in Supplementary Table 1). The gene discussed is STING1; the disease is neoplasm.